Polypeptide having Factor Xa inhibitory activity

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 12, 530324, 530350, 530395, 530858, 435226, A61K 3855, A61K 3858, C07K 1481, C07K 14815

Patent

active

058589708

ABSTRACT:
A novel polypeptide derived from the leech Hirudo medicinalis was found to be able to inhibit Factor Xa thereby reducing the extent of blood coagulation. The polypeptide is useful in treating conditions of excessive blood coagulation. A recombinant organism containing cDNA encoding the polypeptide has been deposited in the ATCC under Accession No. 69134. Recombinant microorganisms able to produce the polypeptide have been deposited in the ATCC under Accession Nos. 69135, 69137 and 69269.

REFERENCES:
patent: 4588587 (1986-05-01), Gasic
patent: 4742004 (1988-05-01), Hartman et al.
patent: 4791100 (1988-12-01), Kramer et al.
patent: 4832849 (1989-05-01), Cardin
patent: 5114922 (1992-05-01), Maschler
patent: 5182113 (1993-01-01), Rigbi
patent: 5403596 (1995-04-01), Rigbi
Baskova et al., Chemical Abstracts, 106:60996w (1986).
Condra et al., "Isolation and Structural Characterization of a Potent Inhibitor of Coagulation Factor Xa from the Leech Haementeria ghilianii", Thrombosis and Homeostasis 61(3): 437-441 (1989).
Methodologies for Protein Disposition Studies, Protein Pharmacokinetics and Metabolism; Plenum Press. New York, 1992. pp. 1-33.
Han et al., (1989) "Cloning and Expression of cDNA Encoding Antistasin, a Leech-Derived Protein Having Anti-Coagulant and Anti-Metastatic Properties", Gene 75:47-57.
Gasic et al., Cancer Res. 44:1633-1636 (1983).
Gasic et al., Cancer Res. 44:5670-5676 (1984).
Gasic et al., Chemical Abstracts 110:185955w (1986).
Hoffman et al., (1992) "Site-Directed Mutagenesis of the Leech-Derived Factor Xa Inhibitor Antistasin", Journ. Biol. Chem., 287:943-949.
Hopp et al., (1988) "A Short Polypeptide Marker Sequence Useful For Recombinant Protein Identification And Purification", Bio/technology 6:1204-1210.
Konrad, Michael W., (1993) "The Immune System as a Barrier to Delivery of Protein Therapeutics", Biological Barriers to Protein Delivery Plenum Press, New York. pp. 409-437.
Nutt et al., (1988) "The Amino Acid Sequence of Antistasin", Journ. Biol. Chem. 263(11): 10162-10164.
Rigbi et al., (1990) Chemical Abstracts, 113:46259W.
Tuszynski et al., (1987) "Isolation and Characterization of Antistasin", 262(20): 9718-9723.
Dunwiddie et al. (1989), J.Biol. Chem. 264(28): 16694-16699.
Sollner et al., Eur. J. Biochem. 219: 937-943 (1994).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polypeptide having Factor Xa inhibitory activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polypeptide having Factor Xa inhibitory activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptide having Factor Xa inhibitory activity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1515926

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.